Restrictive Physiology is a Major Predictor of Poor Outcomes in Children with Hypertrophic Cardiomyopathy Shiraz A Maskatia MD, Jamie A Decker MD, Joseph.

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.
Advertisements

Cardiac Risk In ESRD Patient
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
Cardiac Murmurs Lubna Piracha, D.O. Assistant Professor of Medicine Department of Cardiology.
Azin Alizadehasl, MD. Sarcoidosis is a systemic inflammatory disease of unknown etiology, characterized by non-caseating granulomas. It mainly affects.
Manoel Otávio da Costa Rocha UNIVERSIDADE FEDERAL DE MINAS GERAIS - FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA SAÚDE: INFECTOLOGIA.
DOMENICO CORRADO, MD, PhD University of Padova, Italy
Congestive Heart Failure Stephen Gottlieb, MD Professor of Medicine Director, Cardiomyopathy and Pulmonary Hypertension University of Maryland.
Dr. Meg-angela Christi M. Amores
DIASTOLIC DYSFUNCTION AND HEART FAILURE PHYSIOLOGY, HISTORICAL FEATURES AND CLINICAL PERSPECTIVE Medicine Resident Rounds September 28, 2007 Jacobi Hospital.
Investigator Investigator: Sharma Kattel, MBBS Mentor: Mentor: Yuji Saito, MD, PhD, FACP, FACC Department of Internal Medicine Sisters of Charity Hospital.
Diastolic Dysfunction as Diagnosed and Quantified by Echocardiography LAM-1965AO (07/13) For Broker/Dealer Use Only.
Ventricular Diastolic Filling and Function
Outcomes following simple and complex (Damus- Kaye-Stansel takedown) Ross operations in 62 consecutive pediatric patients Alejandra Bueno MD, David Zurakowski.
Periportal Fibrosis Without Cirrhosis Does Not Affect Outcomes Following Continuous Flow Ventricular Assist Device Implantation Jonathon E. Sargent, BS,
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
Incidence of and Risk Factors for Sudden Cardiac Death in Children with Dilated Cardiomyopathy: A Report from the Pediatric Cardiomyopathy Registry Elfriede.
Diastolic Dysfunction is Common in Asymptomatic HIV Patients Priscilla Y. Hsue 1,2, Husam H. Farah 1,2, Ann F. Bolger 1,2, Swapna Palav 2, Samira Ahmed.
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
The surgical approach to Ebstein's Disease at IBCvT Tîrgu-Mureş
Pulmonary Atresia with Intact Ventricular Septum Ali Sepahdari, MD University of Illinois at Chicago.
Septal ablation in Hypertrophic Cardiomyopathy Charles Knight London Chest Hospital Advanced Angioplasty 2003.
Clinical Features and Ultrasound Parameters in Pulmonary Arterial Hypertension, in Pediatric Cardiology Author: Gáspár Hanga 1 Scientific coordinators:
1 بسم الله الرحمن الرحیم. Atrial and Ventricular Hypertrophy ECG Features and Common Causes ALI BARABADI University of Guilan.
Cardiovascular disease in pregnancy Cardiovascular disease in pregnancy Dr.Z Allameh MD.
Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.
Guidelines for the Echocardiographic Assessment of
Acute Heart Failure in Apical Ballooning Syndrome (Takotsubo/Stress Cardiomyopathy) Clinical Correlates and Mayo Clinic Risk Score Malini Madhavan, MBBS;
Haissam A Haddad, MD, FRCPC, FACC University of Ottawa Heart Institute
Embargoed Until 3:45 p.m. ET, Sunday, Nov. 8, 2015
Anne L. Taylor, M. D. , Susan Ziesche, R. N. , Clyde Yancy, M. D
Thomas Wilson 1,2,3, Vijay Krishnamoorthy MD 1,2, Edward Gibbons MD 4, Ali Rowhani-Rahbar MD MPH PhD 2,5, Adeyinka Adedipe MD 6, Monica S. Vavilala MD.
Introduction BACKGROUND  N on-sustained VT (NSVT) is a known risk factor for poor outcomes in adults with HCM and diastolic dysfunction is linked to poor.
Don’t Worry I am Ok! Goal of project GOAL OF PROJECT  TO AWARE ABOUT HEART DISEASES.  TO UNDERSTAND CAUSES OF HEART DISEASES.  TO AWARE PREVENTIVE.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Phenotypes of Familial Dilated Cardiomyopathy.
以多重死因資料比較台灣美國腦中風 併發吸入性肺炎之趨勢 奇美醫學中心 張嘉祐醫師. Stroke Statistics -- A Report From the American Heart Association Approximately 56% of stroke deaths in 2009.
December 02 1 Vascular mortality: Age-specific hazard ratios for 20 mmHg lower usual SBP deaths at ages
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Spectrum and prognostic significance of arrhythmias.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy in Patients With Pre-Existing Cardiomyopathies.
Prevalence of preserved left ventricular function among patients admitted for pulmonary oedema F.HAZIZA, N.COHEN, J.F.LANDAU, A.C.GUIOMARD. Service de.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
1 Echocardiographic Indices of Increased Left Ventricular Filling Pressure and Dilation After Acute Myocardial Infarction R2 Jungwook Kim Journal of the.
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
Heart & Thalassemia . R.Miri,MD, Interventional Cardiologist.
Valvular Heart Disease, Cardiomyopathies,
Heart Failure With Preserved Left Ventricular Function: Diagnostic and Therapeutic Challenges in Patients With Diastolic Heart Failure  Michael N. Young,
Natural History of Tricuspid Regurgitation: Primary vs Secondary
Obstructive Hypertrophic Cardiomyopathy
DIASTOLIC DYSFUNCTION and DIASTOLIC HEART FAILURE
Mohamed Eid Fawzy, FRCP, FACC, FESC October 6 University Cairo, EGYPT
THE “UNDER-LINING” CAUSE OF RIGHT HEART FAILURE AFTER CARDIAC SURGERY
Clare O’Donnell Paediatric/Adult Congenital Cardiologist
Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic
HYPERTROPHIC CARDIOMYOPATHY(HCM)
Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL.
Figure 6 Risk stratification in hypertrophic cardiomyopathy (HCM)
Figure 2 Echocardiographic methods to estimate left atrial pressure
Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation  Osama E Arafa, MD, Odd R Geiran, MD, PhD, Kai Andersen,
Sildenafil for Improving Outcomes in Patients With Corrected Valvular Heart Disease and Persistent Pulmonary Hypertension: A Multicenter, Double-Blind,
Division of Cardiovascular Diseases No relevant author disclosures
Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.
pulmonary embolism protocol -- EMB review
Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death 
Bar chart of systolic function in healthy individuals, HCM LVH− patients and HCM LVH+ patients. GLS was significantly worse in the HCM LVH+ patients compared.
Bar chart of cardiac volumes and EF in the healthy individuals, HCM LVH− patients and HCM LVH+ patients. Blue bars show the indexed diastolic volumes (EDVI.
Jeffrey B. Geske et al. JCHF 2018;j.jchf
Examples of association between CMR features and abnormal Q waves.
Presentation transcript:

Restrictive Physiology is a Major Predictor of Poor Outcomes in Children with Hypertrophic Cardiomyopathy Shiraz A Maskatia MD, Jamie A Decker MD, Joseph A Spinner BA, Jeffrey J Kim MD, Jack F Price MD, John L Jefferies MD, William J Dreyer MD, E O’Brian Smith PhD, Joseph W Rossano MD, Susan W Denfield MD

Background Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of sudden and heart failure deaths in children 1,2 Previously identified risk factors for death or heart transplant (HT) in children include abnormal BP response to exercise and left ventricular hypertrophy 2 A subgroup of patients with restrictive physiology (RP) with worse outcomes has been described, but data in children is limited 3,4 1. Nugent et al Circulation Decker et al J Am Coll Cardiol Colan et al Circulation Webber et al Circulation (S2) 2008

Hypothesis The presence of restrictive physiology is a major predictor of hospitalization, death or transplant in children with HCM

Methods Retrospective review of patients followed for HCM at Texas Children’s Hospital Inclusion criteria: – Age < 18 years at the time of diagnosis – Follow up time ≥ 1 year – Echocardiogram (echo) evidence of HCM without secondary cause Outcomes analysis included Poisson and Cox regression

Methods RP on echo defined as > 1 echo with one of the following: – Left atrial enlargement without left ventricular dilation – Mitral inflow E/A ratio ≥ 3 – Mitral E/E’ ratio ≥ 10 RP on catheterization (cath) defined as: – Systolic pulmonary artery pressure ≥ 35 mmHg – Left or right ventricular end diastolic pressure ≥ 15 mmHg – Pulmonary vascular resistance index ≥ 4 woods units

Results 444 patients with HCM treated at our institution from 1/1/1985 to 1/1/ patients met inclusion criteria RP by echo was present in 49 (41%) patients – Left atrial enlargement was present in 43 (88%) patients – E/E’ ratio ≥ 10 present in 27 (55%) patients – E/A ratio ≥ 3 present in 9 (18%) patients

17 (14%) patients underwent cath – RP by cath present in 11 (65%) patients – Of the 11 patients with RP by cath, 10 (91%) had RP by echo No evidence of RP present in 69 (58%) patients One patient had RP by cath, and not by echo Results

Patient Characteristics All patients (n=119) Non- restrictive (n=69) Restrictive by Echo (n=49) Restrictive by Cath (n=11) Age at diagnosis (years)10.2 ± ± ± ± 5.5 Male (%)86 (72%)51 (74%)29 (59%)4 (36%) Symptoms at presentation (%)31 (26%)16 (23%)12 (24%)7 (64%) FH of HCM (%)47 (40%)22 (32%)22 (45%)6 (55%) Ventricular arrhythmias (%)9 (7.6%)2 (3%)7 (14%)1 (9%) IVS (z-score)5.7 ± ± ± ± 2.6 Abn BP response (%)35 (29%)13 (19%)19 (39%)3 (27%)

Results Patients with RP by echo – higher ventricular septal z-scores (p=0.03) – more likely to have ventricular arrhythmias (p=0.02 OR=5.6 CI= ) – more likely to have an abnormal blood pressure response to exercise (p=0.01 OR=3.9 CI= ) Patients with RP by cath had higher left ventricular free wall z-scores (p=0.03)

7 patients died; 6 (86%) had RP 3 pts underwent HT; all 3 had RP Aborted sudden cardiac death (aSCD) occurred in 9 pts; 6 (67%) had RP RP by echo or cath had a positive predictive value of 17% and a negative predictive value of 98% for death or HT Results

Risk FactorHazard Ratio (95% Conf Int)P-value Hospitalization Restrictive by Echo3.5 ( ) 0.01 Restrictive by Cath11.5 ( ) <0.01 Restrictive on presentation 7.4 ( ) 0.02 Female 4.8 ( ) <0.01 Age at presentation (years) 1.1 ( ) 0.05 Symptoms at presentation 1.7 ( ) 0.19 Abnormal BP response 2.1 ( ) 0.17 Septal wall thickness z-score 1.02 ( ) 0.63 Death or Aborted Sudden Cardiac Death Restrictive by Echo3.8 ( ) 0.02 Restrictive by Cath4.7 ( ) 0.05 Restrictive on presentation 9.0 ( ) 0.05 Female 1.5 ( ) 0.43 Age at presentation (years) 1.02 ( ) 0.70 Symptoms at presentation 6.5 ( ) <0.01 Septal wall thickness z-score 1.03 ( ) 0.67 Death or Heart Transplant Restrictive by Echo5.7 ( ) 0.04 Restrictive by Cath89 ( ) <0.01 Restrictive on presentation 22 ( ) 0.04 Female 1.33 ( ) 0.69 Age at presentation (years) 0.93 ( ) 0.37 Symptoms at presentation 8.0 ( ) <0.01 Septal wall thickness z-score 0.98 ( ) 0.98

Limitations Retrospective analysis Determination of left atrial volume was subjective Only 14% of patients in the study underwent cath – may result in selection bias.

Conclusions Children with hypertrophic cardiomyopathy without restrictive physiology have a good prognosis Children with hypertrophic cardiomyopathy and restrictive physiology accounted for the majority of poor outcomes Patients with evidence of restrictive physiology on echocardiogram and symptoms should undergo further hemodynamic assessment by cardiac catheterization